Literature DB >> 8282809

Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes.

S L Hempel1, M M Monick, G W Hunninghake.   

Abstract

We and others have previously demonstrated that human alveolar macrophages produce more PGE2 in response to lipopolysaccharide (LPS) than do blood monocytes. We hypothesized that this observation was due to a greater increase in prostaglandin H synthase-2 (PGHS-2) enzyme mass in the macrophage compared to the monocyte. To evaluate this hypothesis, alveolar macrophages and blood monocytes were obtained from healthy nonsmoking volunteers. The cells were cultured in the presence of 0 to 10 micrograms/ml LPS. LPS induced the synthesis of large amounts of a new 75-kD protein in human alveolar macrophages, and a lesser amount in monocytes. Synthesis of this protein required more than 6 h and peaked in 24 to 48 h; the protein reacted with an anti-PGHS-2 antibody prepared against mouse PGHS-2. Associated with synthesis of the protein was a marked increase in LPS-stimulated and arachidonic acid-stimulated synthesis of PGE2 by alveolar macrophages compared to monocytes. Cells not exposed to LPS contained only PGHS-1 and synthesized very little PGE2 during culture or in response to exogenous arachidonic acid. An LPS-induced mRNA, which hybridized to a human cDNA probe for PGHS-2 mRNA, was produced in parallel with production of this new protein and was produced in much greater amounts by alveolar macrophages compared to blood monocytes. This mRNA was not detectable in cells not exposed to LPS. In contrast, both types of cells contain mRNA, which hybridizes to a cDNA probe for PGHS-1. This mRNA did not increase in response to LPS. LPS also had no effect on PGHS-1 protein. These data demonstrate that PGE2 synthesis in human alveolar macrophages and blood monocytes correlates to the mass of PGHS-2 in the cell. We conclude that the greater ability of the macrophage to synthesize PGE2 in response to LPS is due to greater synthesis of PGHS-2 by the macrophage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8282809      PMCID: PMC293791          DOI: 10.1172/JCI116971

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Enhanced 5-lipoxygenase activity in lung macrophages compared to monocytes from normal subjects.

Authors:  T D Bigby; M J Holtzman
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

2.  Organization and expression of the immediate early genes of human cytomegalovirus.

Authors:  M F Stinski; D R Thomsen; R M Stenberg; L C Goldstein
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

3.  Comparative oxidative microbicidal activity of human blood monocytes and alveolar macrophages and activation by recombinant gamma interferon.

Authors:  B Kemmerich; T H Rossing; J E Pennington
Journal:  Am Rev Respir Dis       Date:  1987-08

4.  Recovery of porcine aortic endothelial cell prostaglandin synthesis following inhibition by sublethal concentrations of hydrogen peroxide.

Authors:  A Barchowsky; R S Kent; A R Whorton
Journal:  Biochim Biophys Acta       Date:  1987-03-11

5.  Prostacyclin biosynthesis in cultured vascular endothelium is limited by deactivation of cyclooxygenase.

Authors:  A F Brotherton; J C Hoak
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

6.  Human alveolar macrophage arachidonic acid metabolism.

Authors:  G P Brown; M M Monick; G W Hunninghake
Journal:  Am J Physiol       Date:  1988-06

7.  Human alveolar macrophages suppress interleukin-1 (IL-1) activity via the secretion of prostaglandin E2.

Authors:  M Monick; J Glazier; G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1987-01

8.  Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages.

Authors:  P R Bachwich; S W Chensue; J W Larrick; S L Kunkel
Journal:  Biochem Biophys Res Commun       Date:  1986-04-14       Impact factor: 3.575

9.  Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites.

Authors:  A A Aderem; D S Cohen; S D Wright; Z A Cohn
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

10.  Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages.

Authors:  S L Newman; J E Henson; P M Henson
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

View more
  56 in total

1.  Effect of topically applied cyclooxygenase-2-selective inhibitors on arachidonic acid- and tetradecanoylphorbol acetate-induced dermal inflammation in the mouse.

Authors:  V Puigneró; J Queralt
Journal:  Inflammation       Date:  1997-08       Impact factor: 4.092

2.  PAMAM dendrimers as nano carriers to investigate inflammatory responses induced by pulmonary exposure of PCB metabolites in Sprague-Dawley rats.

Authors:  Orarat Wangpradit; Andrea Adamcakova-Dodd; Katharina Heitz; Larry Robertson; Peter S Thorne; Gregor Luthe
Journal:  Environ Sci Pollut Res Int       Date:  2015-09-24       Impact factor: 4.223

3.  A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors.

Authors:  C Brideau; S Kargman; S Liu; A L Dallob; E W Ehrich; I W Rodger; C C Chan
Journal:  Inflamm Res       Date:  1996-02       Impact factor: 4.575

4.  Inhibition of nitric oxide production in LPS-stimulated RAW 264.7 cells by stem bark of Ulmus pumila L.

Authors:  Taewoo Joo; Kandhasamy Sowndhararajan; Sunghyun Hong; Jaehak Lee; Sun-Young Park; Songmun Kim; Jin-Woo Jhoo
Journal:  Saudi J Biol Sci       Date:  2014-05-05       Impact factor: 4.219

Review 5.  [New non-steroidal anti-rheumatic drugs: selective inhibitors of inducible cyclooxygenase].

Authors:  D O Stichtenoth; H Zeidler; J C Frölich
Journal:  Med Klin (Munich)       Date:  1998-07-15

6.  NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes.

Authors:  P Minuz; M Degan; S Gaino; A Meneguzzi; V Zuliani; C L Santonastaso; P D Soldato; A Lechi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

7.  Induction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation.

Authors:  P Patrignani; G Santini; M R Panara; M G Sciulli; A Greco; M T Rotondo; M di Giamberardino; J Maclouf; G Ciabattoni; C Patrono
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

8.  Expression of cyclooxygenase-2 in human esophageal squamous cell carcinomas.

Authors:  Jian-Gang Jiang; Jiang-Bo Tang; Chun-Lian Chen; Bao-Xing Liu; Xiang-Ning Fu; Zhi-Hui Zhu; Wei Qu; Katherine Cianflone; Michael-P Waalkes; Dao-Wen Wang
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

9.  Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.

Authors:  G D Anderson; S D Hauser; K L McGarity; M E Bremer; P C Isakson; S A Gregory
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Altered monocyte cyclo-oxygenase response in non-obese diabetic mice.

Authors:  H Beyan; L R Buckley; S A Bustin; N Yousaf; P Pozzilli; R D Leslie
Journal:  Clin Exp Immunol       Date:  2008-11-24       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.